News: Research
UT News
Cytomegalovirus Breakthrough Could Lead to New Treatments
A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.
AI Tips Off Scientists to New Drug Target to Fight Monkeypox Virus
The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.
A New Tool for Healthcare Gives Better Outbreak Forecasts
Pinpointing an outbreak’s peak, the approach can boost health systems’ preparedness and risk communication.
New Gene-Editing Tech Holds Promise for Treating Complex Genetic Diseases
Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.
High-Resolution Structure Reveals How Microcins Target Bacteria
The Davies Lab and NIH researchers reveal the first high-resolution structure of a microcin binding its bacterial receptor.
Re-engineered Antibodies Kill Bacteria Directly
These antibodies use a clever trick to slip deep into a bacteria’s outer membrane, where they can do real damage.
Davies Lab Research Finds Wide Diversity of Microcins
The study, recently published in Nature Communications, could lead to new ways to treat antibiotic-resistant infections.
Maynard, McLellan Labs Study Boosting Pertussis Vaccines
Researchers in the labs of LCID members Jennifer Maynard and Jason McLellan have made discoveries in understanding and enhancing immunity against pertussis.
Research Identifies Key Antibodies for Development of Broadly Protective Norovirus Vaccine
Discovery brings us one step closer to vaccine and treatment for prevalent virus.
Newly Discovered Antimicrobial Could Prevent or Treat Cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.
